Terms: = Breast cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270 AND Treatment
6 results:
1. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.
Ding L; Bi Z; Wu J; Zhu J; Yu Y; Yao HR; Liu YM
Arch Gynecol Obstet; 2023 Mar; 307(3):891-901. PubMed ID: 35708782
[TBL] [Abstract] [Full Text] [Related]
2. Targeted gene next-generation sequencing reveals genomic profile in a cohort of 46 Chinese patients with breast cancer.
Yao J; Chen Q; Zhu JQ; Cai RG
J Gene Med; 2022 Jun; 24(6):e3420. PubMed ID: 35470535
[TBL] [Abstract] [Full Text] [Related]
3. The lncRNA hoxa11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axis.
Xu Y; Ren Z; Wang X; Ren M
J Gene Med; 2022 May; 24(5):e3413. PubMed ID: 35106863
[TBL] [Abstract] [Full Text] [Related]
4. Tetraarsenic oxide affects non-coding RNA transcriptome through deregulating polycomb complexes in MCF7 cells.
Jeong J; Hamza MT; Kang K; Jo DS; Bae IJ; Kim D; Cho DH; Bunch H
Adv Biol Regul; 2021 May; 80():100809. PubMed ID: 33932728
[TBL] [Abstract] [Full Text] [Related]
5. Long non‑coding RNA hoxa11‑AS promotes cell proliferation and metastasis in human breast cancer.
Su JC; Hu XF
Mol Med Rep; 2017 Oct; 16(4):4887-4894. PubMed ID: 28791375
[TBL] [Abstract] [Full Text] [Related]
6. Lack of Prognostic Impact of Adjuvant Radiation on Oncologic Outcomes in Elderly Women with breast cancer.
Omidvari S; Talei A; Tahmasebi S; Moaddabshoar L; Dayani M; Mosalaei A; Ahmadloo N; Ansari M; Mohammadianpanah M
Asian Pac J Cancer Prev; 2015; 16(17):7813-8. PubMed ID: 26625803
[TBL] [Abstract] [Full Text] [Related]
